SEARCH RESULTS FOR: "Tag: BMY"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2024(2)
2023(8)
2022(2)
2021(3)
2020(3)
2019(11)
2018(6)
2017(9)
2016(13)
2015(10)
2014(3)
CATEGORIES
5-Minute Market Rundown(2)
Analyst Downgrades(3)
Analyst Update(7)
Analyst Upgrades(1)
Best and Worst Stocks(1)
Buzz Stocks(12)
Earnings Preview(1)
Editor's Pick(1)
Expectational Analysis(1)
General(8)
Indicator of the Week(1)
Intraday Option Activity(7)
Midday Market Check(7)
Opening View(4)
Options Recommendations(1)
Quantitative Analysis(4)
Stock Market News(5)
Stocks On the Move(9)
The Week Ahead(2)
Trade Postmortem(1)
Trader Content(1)
Unusual Trading Activity(1)

2/6/2024 9:00 AM
Biopharmaceutical stock Bristol-Myers Squibb Co (NYSE:BMY) is in focus this morning, after a downgrade to "neutral" from "buy" at Redburn-Atlantic. The analyst in coverage also lowered its price targe...
1/23/2024 2:48 PM
After eight-straight monthly losses starting in April 2023, the shares of pharmaceutical concern Bristol-Meyers Squibb Co (NYSE:BMY) started to rebound in December, though were swiftly rejected by the...
12/29/2023 2:59 PM
Despite the low-volume, post-Christmas trading environment, where headlines are few and far between, there was plenty to unpack for the final week of 2023. The Dow Jones Industrial Average (DJI) co...
12/26/2023 10:24 AM
Pharmaceutical giants AstraZeneca plc (NASDAQ:AZN) and Bristol-Myers Squibb Co (NYSE:BMY) announced new acquisitions today. The former acquired China's Gracell Biotechnologies (GRCL) for $1.2 bill...
12/22/2023 11:07 AM
Bristol-Myers Squibb Co (NYSE:BMY) stock is on the rise today, up 2.8% at $52.71 at last glance, after news that the biopharmaceutical company is acquiring Karuna (KRTX) for $14 billion. The deal, wh...